Entrada Therapeutics to Present at Goldman Sachs Global Healthcare Conference
Get Alerts TRDA Hot Sheet
Join SI Premium – FREE
BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™) therapeutics as a new class of medicines, today announced that the Company will participate in-person at the Goldman Sachs Global Healthcare Conference. A fireside chat with Dipal Doshi, President and Chief Executive Officer will be held at Terranea in Rancho Palos Verdes, CA on Tuesday, June 14, 2022 at 2:40 p.m. Pacific Time/5:40 p.m. Eastern Time.
A live webcast will be available on the Investor Relations section of the Company’s website at www.entradatx.com. A replay will be available on the Entrada website for 90 days following the event.
About Entrada Therapeutics
Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicle (EEV™) therapeutics, to engage intracellular targets that have long been considered inaccessible and undruggable. The Company’s EEV therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index. Through its proprietary, highly versatile and modular EEV platform, Entrada is building a robust development portfolio of oligonucleotide-, antibody- and enzyme-based programs for the potential treatment of neuromuscular diseases, immunology, oncology and diseases of the central nervous system. The Company’s lead oligonucleotide programs include ENTR-601-44 targeting Duchenne muscular dystrophy (DMD) and ENTR-701 targeting myotonic dystrophy type 1 (DM1).
For more information about Entrada, please visit our website, www.entradatx.com, and follow us on Twitter and LinkedIn.
Investor and Media Contact
Karla MacDonald
VP, Corporate Communications and Investor Relations
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Back to School, Back to Basics: What Every Student Should Know About Bed Bugs and Cockroaches This Move-In Season
- Nearly Half of Americans Say Carrying Credit Card Debt Is “Normal” as U.S. Balances Reach $1.26 Trillion
- Fantastic Services Passes Landmark of 250,000 Deposit-Saving End of Tenancy Cleans in London
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Goldman Sachs, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share